These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effects of nimodipine in experimental permanent focal cerebral ischemia].
    Author: Wassmann H, Marinov M, Moskopp D.
    Journal: Zentralbl Neurochir; 1992; 53(3):141-7. PubMed ID: 1414081.
    Abstract:
    In a controlled double blind experiment the influence of a continuous i.v. infusion of Nimodipine (1 microgram kg-1 min-1) upon infarct size, histopathology and neurological outcome in rats with permanent middle cerebral artery (MCA) occlusion was examined. The infusion was started 20 min. before the induction of ischemia and continued 4 hours thereafter. The nimodipine treated animals were subdivided into hypotensive (MABP lower than 85 mmHG for more than 5 minutes after arterial occlusion) and normotensive groups. Infarction size, documented by TTC, H&E and Nissl staining was significantly smaller (p less than 0.001) in nimodipine normtonic rats than the lesions in placebo and saline treated rats, as well as compared with hypotonic nimodipine animals (largest infarction). These differences were found to be entirely at the expense of the cortical (frontoparietal) component of the lesion, suggesting "penumbra" action of the drug. Moreover, nimodipine normotonic rats displayed lower cortical neuronal injury in the periinfarct zone. These findings were corroborated by corresponding better neurological scores. Our results indicate that nimodipine is effective in reducing focal cerebral ischemia, provided the MABP is maintained higher than 85 mmHg.
    [Abstract] [Full Text] [Related] [New Search]